United Therapeutics Corporation (UTHR) has exhibited a strong uptrend over recent months, propelled by significant gains in the last 30 days and quarter. The stock surged approximately 17% in the past month, marked by volatility and a sharp 12.5% single-day advance on positive clinical trial data. Year-to-date, shares have climbed 16-17%, placing UTHR in "deep bull territory" with an 87% rise over the past year. Chart structure shows price action respecting an ascending trendline from prior lows, with recent consolidation after breaking prior highs. While some traders note potential descending triangle or head-and-shoulders patterns, the prevailing momentum favors continuation higher absent a breakdown.
UTHR trades decisively above its key moving averages, reinforcing the uptrend. The 50-day simple moving average sits around $536-$540, the 100-day near $511-$513, and the 200-day at approximately $450. Shorter-term 20-day and 5-day averages hover closer to $570, with price action above these levels signaling short-term strength. Technical summaries show mostly buy signals from moving averages across multiple periods, with 8 buys and 4 sells noted on one platform.
Momentum indicators present a neutral to bullish picture. The Relative Strength Index (RSI) ranges from 51 to 64 across sources, indicating neither overbought nor oversold conditions, allowing room for further upside. MACD readings vary but lean positive, with values like 16.53 signaling buy opportunities and others at -0.62 suggesting caution in overbought scenarios. Oscillators overall rate neutral, supporting the ongoing trend without immediate reversal risks.
Traders eye support zones at $560-$567, aligning with recent lows and pivot points, while resistance clusters around $585-$602, near prior swing highs. The 52-week high at $607.89 serves as a major overhead barrier. Accumulated volume supports these levels, with potential for bounces or breaks defining the next move. Pivot calculations place intraday points near current levels around $570-$577.
Volume has spiked on upward moves, notably during the recent 12.5% rally, confirming conviction behind the advance. Average daily volume exceeds 400,000-500,000 shares, with recent sessions showing elevated participation. This aligns with trend continuation, though lighter volume in consolidation phases warrants monitoring for accumulation or distribution.
Tickeron’s AI Daily Buy/Sell Signals leverage artificial intelligence to scrutinize vast arrays of market data, technical indicators, and historical price patterns, generating actionable buy or sell signals for stocks like UTHR. These signals draw from trend recognition, momentum shifts, and pattern matching observed in past market behavior, providing traders with potential entry and exit points. By integrating RSI, MACD, moving averages, and volume anomalies, the AI identifies high-probability setups to confirm trends or spot reversals. Professional traders often use these signals to validate chart analysis, manage risk, and enhance decision-making in volatile environments. Explore the AI signals for UTHR to see how they align with the current technical setup.
Looking ahead, traders will monitor support at $560-$567 for potential bounces, with a breakdown below risking deeper pullbacks toward the 50-day moving average near $540. Upside targets focus on resistance at $585-$602 and the 52-week high of $608, where breakouts could accelerate the uptrend. Watch RSI for overbought divergences above 70 and MACD for histogram shifts. Volume confirmation on moves through these levels will be crucial, alongside any resolution of consolidation patterns for directional clarity.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
A.I.dvisor indicates that over the last year, UTHR has been loosely correlated with MNKD. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if UTHR jumps, then MNKD could also see price increases.
| Ticker / NAME | Correlation To UTHR | 1D Price Change % | ||
|---|---|---|---|---|
| UTHR | 100% | +2.08% | ||
| MNKD - UTHR | 38% Loosely correlated | -2.38% | ||
| GERN - UTHR | 37% Loosely correlated | +1.08% | ||
| ALNY - UTHR | 36% Loosely correlated | +2.52% | ||
| CBIO - UTHR | 36% Loosely correlated | -0.32% | ||
| INSM - UTHR | 35% Loosely correlated | +11.65% | ||
More | ||||
| Ticker / NAME | Correlation To UTHR | 1D Price Change % |
|---|---|---|
| UTHR | 100% | +2.08% |
| Pharmaceuticals: Generic industry (211 stocks) | 48% Loosely correlated | -0.17% |
| Pharmaceuticals industry (374 stocks) | 28% Poorly correlated | -0.11% |